-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JDIxCDpw3e726mPaTkosM5xTIjMi1HOfIQqif3iYakzvgLAUx5C3sYQRLVUjzWMn 2VRbMXmVvW5qsED4Tn3lqA== 0000912057-96-006546.txt : 19960418 0000912057-96-006546.hdr.sgml : 19960418 ACCESSION NUMBER: 0000912057-96-006546 CONFORMED SUBMISSION TYPE: 10-C PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19960411 FILED AS OF DATE: 19960417 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: LIFECORE BIOMEDICAL INC CENTRAL INDEX KEY: 0000028626 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 410948334 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-C SEC ACT: 1934 Act SEC FILE NUMBER: 000-04136 FILM NUMBER: 96547809 BUSINESS ADDRESS: STREET 1: 3515 LYMAN BLVD CITY: CHASKA STATE: MN ZIP: 55318-3051 BUSINESS PHONE: 6123684300 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC INC DATE OF NAME CHANGE: 19861214 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN MEDICAL RESEARCH INC DATE OF NAME CHANGE: 19691118 10-C 1 10-C SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-C REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ INTERDEALER QUOTATION SYSTEM FILED PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 13a-17 OR 15d-17 THEREUNDER Lifecore Biomedical, Inc. ------------------------------------------------ (Exact name of issuer as specified in charter) 3515 Lyman Boulevard, Chaska, MN 55318-3051 ---------------------------------------------------- (Address of principal executive offices) Issuer's telephone number, including area code: (612) 368-4300 -------------------------------- I. CHANGE IN NUMBER OF SHARES OUTSTANDING Indicate any change (increase or decrease) of 5% or more in the number of shares outstanding. 1. Title of security: Common Stock, $.01 Par Value Per Share -------------------------------------------------------- 2. Number of shares outstanding before the change: 10,612,041 --------------------------- 3. Number of shares outstanding after the change: 12,112,041 ---------------------------- 4. Effective date of change: April 11, 1996 ------------------------------------------------- 5. Method of change: Specify method (such as merger, acquisition, exchange, distribution, stock split, reverse split, acquisition of stock for treasury, etc.): Private Offering ---------------- Give brief description of transaction: The Company sold 1,500,000 shares of ------------------------------------ newly issued common stock in a Regulation S Offering. - -------------------------------------------------------------------------------- II. CHANGE IN NAME OF ISSUER 1. Name prior to change: ----------------------------------------------------- 2. Name after change: -------------------------------------------------------- 3. Effective date of charter amendment changing name: ------------------------ 4. Date of shareholder approval of change, if required: ---------------------- Date: April 15, 1996 /s/ Dennis J. Allingham --------------------- ---------------------------------------------- Dennis J. Allingham, Chief Financial Officer (Officer's signature & title) -----END PRIVACY-ENHANCED MESSAGE-----